Description
GenX Pharma BPC-157 + TB-500 is a combination peptide product featuring two compounds investigated in preclinical research involving tissue biology, cellular signalling, and repair-related pathways.
BPC-157 is a synthetic peptide derived from a sequence associated with a protein found in gastric juice. TB-500 is commonly marketed as a thymosin beta-4-related peptide; however, the exact composition and identity of a product labelled TB-500 should be verified rather than assumed to be identical to full-length thymosin beta-4.
The combination is of interest in laboratory research examining how different peptide pathways may interact in experimental models of tissue and cellular responses.
Product Benefits and Research Areas
- BPC-157 Research: Investigated in preclinical studies involving cellular signalling and tissue-related biological processes.
- TB-500 Research: Associated with research into thymosin beta-4-related pathways, including cell migration and actin regulation.
- Cellular Signalling Studies: Both compounds are studied in experimental research involving cellular responses and biological signalling.
- Tissue Biology Research: The individual compounds have been investigated in preclinical models related to tissue structure and repair processes.
- Combination Research: Provides an opportunity to investigate two different peptide compounds within laboratory research settings.
Understanding the Ingredients
BPC-157: A synthetic peptide studied primarily in preclinical research. Investigations have explored its interaction with various cellular and tissue-related pathways, but reliable clinical evidence establishing benefits in humans remains insufficient.
TB-500: A name commonly used for products associated with thymosin beta-4 fragments. Thymosin beta-4 is involved in biological processes such as actin regulation and cell migration. The exact sequence and purity of the supplied TB-500 should be confirmed through appropriate product documentation.
Important Safety Information
BPC-157 and TB-500 are not established or approved treatments for injuries, muscle recovery, tendon problems, or other medical conditions. Evidence from laboratory and animal studies does not establish safety or effectiveness in humans. The safety of combining these compounds has not been adequately established, and product identity, purity, and quality may vary. This product should be regarded as a research compound, not as a product for self-administration or human use.
Product Details: BPC-157 + TB-500 combination, 10 mg as stated in the product title, supplied as a pack of 5 vials. Confirm the individual amount of each ingredient per vial with the manufacturer before publishing a split composition.
Reviews
There are no reviews yet.